Serdecznie zapraszamy na drugi wykład z serii AMU Invited Lecture Series in MODERN CATALYSIS 3, finansowanej w ramach programu Inicjatywa Doskonałości – Uczelnia Badawcza.
Wykład pt. „ Copper- and Phosphine-catalyzed stereoselective borylation methods for sustainable chemistry” wygłosi prof. dr. Webster Santos z Virginia Tech (USA),(https://chem.vt.edu/people/faculty/teaching-and-research/wsantos.html), we wtorek 17 października 2023 roku, o godz. 10.00, w Centrum Zaawansowanych Technologii UAM (sala D-111/4-6, pierwsze piętro).
Badania realizowane przez prof. Webstera Santosa dotyczą zastosowania zaawansowanej syntezy organicznej w chemii medycznej i biologii. Nadrzędnym elementem badań grupy Santosa jest opracowanie nowych metod syntezy związków oddziaływujących na zdrowie człowieka, także z udziałem procesów katalitycznych.
Prof. dr. Webster Santos received his BSc and PhD from the University of Virginia under Prof. Timothy Macdonald. Following his doctoral studies, he moved to Harvard University as a Ruth Kirschtein NIH fellow with Prof. Gregory Verdine. At Harvard, he performed chemical biology studies targeting RNA structures as well as HIV-1 integrase. In 2006, he started as an assistant professor of chemistry at Virginia Tech and was promoted to associate then full professor in 2018. He currently serves as the director of the Virginia Tech Center for Drug Discovery and executive officer of the Virginia Drug Discovery Consortium. He held a chaired position as the Blackwood Junior Faculty fellow of Life Science and is currently the Agnes and Cliff Lilly faculty fellow of drug discovery. He is a co-founder of four start-up companies: SphynKx Therapeutics, Continuum Biosciences, S1P Therapeutics and Uncoupler Biosciences. He serves on the editorial boards of Medicinal Research Reviews, Molecules (Medicinal Chemistry Section) and Current Topics in Medicinal Chemistry, and is the recipient of numerous awards, including the Innovators Award, American Chemical Society Young Investigator, Chemical Communications Emerging Investigator, Molecular Biosystems Emerging Investigator, and Fellow of the Royal Society of Chemistry. He serves as a standing member of the National Institutes of Health Chemical Biology and Probes study section and is an inventor on 21 issued and pending patents.
Wykład organizowany jest Laboratorium Stosowanej i Zrównoważonej Katalizy
przez Centrum Zaawansowanych Technologii UAM.